Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis - Wikidata - awgldk - TriplyDB

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

http://www.wikidata.org/entity/Q37247725

about

New agents for the treatment of drug-resistant Mycobacterium tuberculosis Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.[Better search strategies, hopeful candidates. The search for new antimycobacterial drugs].The cell envelope glycoconjugates of Mycobacterium tuberculosis Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I.An update on the use of rifapentine for tuberculosis therapy.Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors.New drugs and regimens for treatment of TB.A biocatalytic approach to capuramycin analogues by exploiting a substrate permissive N-transacylase CapW.Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target.Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.Reconsidering some approved antimicrobial agents for tuberculosis.Therapeutic efficacy of SQ641-NE against Mycobacterium tuberculosis.Recent derivatives from smaller classes of fermentation-derived antibacterials.Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment.The anti-tuberculosis agents under development and the challenges ahead.Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.Chemical modification of capuramycins to enhance antibacterial activity Functional and kinetic analysis of the phosphotransferase CapP conferring selective self-resistance to capuramycin antibiotics.In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein Spray Drying Strategies to Stop Tuberculosis

P2860

Q26751463-EFF847D8-431E-421B-8345-97A2CD19893B Q28833309-636A575E-7C4E-4C92-97FC-86F27AC870E2 Q30318128-FCC553B7-6C17-409E-A86C-EED121BBECB2 Q34423962-E6DC12D7-601D-492F-B496-282666FA431B Q34976154-3B4C26E4-D5D8-47E2-BFFF-7010369B9C13 Q35084363-4649A4DC-7214-4A4D-9E5D-DAE81472657A Q35243846-729AEA16-2B82-41FC-9D60-9EB009F555E6 Q35579500-E4A734DC-D5BE-4767-9B69-CE7469783185 Q35662238-9D45784E-9B81-4C13-A547-3F9FA43FD2E6 Q36105224-8B9F25D8-6035-4CBF-BBC9-07D9EDB3F2D4 Q36825354-047E337D-1956-4D9D-A137-E5A7C9269960 Q36894291-5BF2616F-C2DD-40A7-B888-22D84C22A9A5 Q37337116-4E715F12-24EE-4D0D-8A71-970E9EF3EF9F Q37403156-DCEF911E-ED87-4DE8-BE83-CE1B619D28A6 Q37409878-05671640-9B71-49F6-A474-F3B20187E901 Q37544338-B298F801-6D3D-4C17-A9F7-D4AD3B0BB9F3 Q37964009-52060C33-F222-49C8-9C32-1D20D645AE2A Q38044744-D85E37FA-7B22-4798-BB18-3E915CBEB7A4 Q38617197-3E6AB24F-F883-46EB-BF30-F157A13C1152 Q38782638-2580AE31-B1F2-43C7-A745-89610EFD2E65 Q39615555-1C721D91-2ACB-4764-B08C-545B16D6883F Q40105078-566D5DD0-2637-4BB7-8CD7-E4B525A3659D Q42374803-05F280CD-0355-493D-847F-1E224349FCEB Q58698851-C514CF08-A0E9-422E-A29D-7676CFF24B1E Q59291746-8EA816EE-CA90-4B85-86E1-B12BED428B72

P2860

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

http://www.wikidata.org/entity/Q37247725

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

@en

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis.

@nl

type

label

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

@en

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis.

@nl

prefLabel

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

@en

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis.

@nl

P1433

Q37247725-1A18136A-416C-4486-B337-10459E7B5C52

P1476

Q37247725-3627941F-86BD-48E5-8CA3-E176A7E23743

P2093

Q37247725-52533BB6-BC4F-4928-805F-4BE12FA80242

Q37247725-64EA9C5C-A4B0-4989-A29B-35D914240F55

Q37247725-89946A91-EE84-45DC-9C3A-59D76C53FEB5

Q37247725-A4F87969-E44B-49EF-BB1E-E78BE5DEF0C9

Q37247725-A88E234D-14C8-4EFE-8DDA-CBA8169662BB

Q37247725-D70DFDDC-7ADD-43BC-9B42-16316A1DDE86

P2860

Q37247725-135689E3-5B44-48E6-A842-365C6C3984F7

Q37247725-155D81AA-8029-4903-AFA6-84B4C1489C4C

Q37247725-630F31BC-B4C5-4E19-8A13-D60F94EBC73A

Q37247725-7E5BF100-10CF-4184-880A-8E854586ECB1

Q37247725-9C7A302C-AAD2-4EE6-8E6E-1C5B2610CAD5

Q37247725-A196097A-6146-4E94-BA34-28E9EE276885

Q37247725-B035EE37-084B-48B3-9C32-CFB520DB36A9

Q37247725-B27BE3C3-5E8C-40C9-B266-FCBDC1DE80EB

P304

Q37247725-AB757ADD-FA9C-46EC-BF19-1BB0F152EF7D

P31

Q37247725-6E0E5277-E32B-4023-92CB-64CA99C6248D

P356

Q37247725-33F926C0-5B0C-455E-B30A-CD9E2D4C1A79

P407

Q37247725-A228847E-80DC-457A-A57E-C70CC96D353F

P433

Q37247725-7DA1E998-E71F-4B1E-9537-26C4E1B47605

P478

Q37247725-E9FAC98E-6818-487A-9677-FD537EEEDF40

P577

Q37247725-A48B3EC4-ECCC-4DCC-A30F-24B4982B431D

P5875

Q37247725-52337C7C-46D5-4521-A5BE-8A86951B2A9C

P698

Q37247725-9C5BB812-6CD7-4F06-9FFE-47FC814C45CF

P921

Q37247725-94D6F818-F726-4511-B95F-4B518281F4AE

P932

Q37247725-E2D99F0A-8CF3-474B-AF55-08984837E748

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

@en

P2093

Boris V Nikonenko

http://www.w3.org/2001/XMLSchema#string

Carol A Nacy

http://www.w3.org/2001/XMLSchema#string

Elena Bogatcheva

http://www.w3.org/2001/XMLSchema#string

Leo Einck

http://www.w3.org/2001/XMLSchema#string

Marina Protopopova

http://www.w3.org/2001/XMLSchema#string

Venkata M Reddy

http://www.w3.org/2001/XMLSchema#string

P2860

Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis.

Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.

In vitro antimycobacterial activities of capuramycin analogues.

Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.

Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

P304

3138-3139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00366-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24400897

http://www.w3.org/2001/XMLSchema#string

P698

19414567

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

2704676

http://www.w3.org/2001/XMLSchema#string